About LCMN

The laboratory of cellular and molecular neurotherapies (LCMN) is a multi-disciplinary structure aiming at promoting interactions between clinicians and biologists in an environment favoring the development of novel therapeutic strategies for neurodegenerative diseases. LCMN is part of the Department of Clinical Neurosciences of the Lausanne University Hospital (CHUV-UNIL)

The general strategy of the group is to develop a pre-clinical research program on neurodegenerative diseases with  the development of relevant and predictive genetic models of CNS diseases (with a particular emphasis on Huntington's disease), investigation of disease mechanisms, identification and validation of therapeutic targets with a potential transfer to the clinic in collaboration with the Department of Clinical Neurosciences at the CHUV.